GSA Capital Partners’s Atossa Therapeutics ATOS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $42K | Buy |
+51,029
| New | +$42K | ﹤0.01% | 1668 |
|
|
2024
Q1 | – | Sell |
-449,082
| Closed | -$395K | – | 1594 |
|
|
2023
Q4 | $395K | Buy |
449,082
+101,690
| +29% | +$89.4K | 0.03% | 954 |
|
|
2023
Q3 | $256K | Buy |
347,392
+44,788
| +15% | +$33K | 0.02% | 1165 |
|
|
2023
Q2 | $381K | Buy |
+302,604
| New | +$381K | 0.04% | 907 |
|
|
2022
Q4 | – | Sell |
-71,901
| Closed | -$60K | – | 1454 |
|
|
2022
Q3 | $60K | Buy |
+71,901
| New | +$60K | 0.01% | 1409 |
|
|
2022
Q2 | – | Sell |
-66,223
| Closed | -$83K | – | 1390 |
|
|
2022
Q1 | $83K | Buy |
+66,223
| New | +$83K | 0.01% | 1311 |
|
|
2021
Q2 | – | Sell |
-22,925
| Closed | -$48K | – | 1310 |
|
|
2021
Q1 | $48K | Buy |
+22,925
| New | +$48K | 0.01% | 1031 |
|